ADLYXIN
- Product NDC
- 0024-5747
- 11-digit product format
- 000245747
- Labeler code
- 0024
- Product ID
- 0024-5747_7ea21219-5fcf-4575-acfd-7ff02629e07b
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Lixisenatide
- Dosage form
- INJECTION, SOLUTION
- Route
- SUBCUTANEOUS
- Labeler
- sanofi-aventis U.S. LLC
- Application
- BLA208471
- Marketing category
- BLA
- Marketing start
- 2016-07-27
- Marketing end
- 0000-00-00
- Substance
- LIXISENATIDE
- Active strength
- 100 ug/mL
- Pharmacologic classes
- GLP-1 Receptor Agonist [EPC], Glucagon-Like Peptide 1 [CS], Glucagon-like Peptide-1 (GLP-1) Agonists [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 0024-5747-02 | 00024574702 | 2 SYRINGE in 1 CARTON (0024-5747-02) > 3 mL in 1 SYRINGE | 2 syringe | 2016-07-27 | 0000-00-00 | No | No | Current |